about
Plasma adiponectin levels correlate positively with an increasing number of components of frailty in male elders.The protective effect of eupafolin against TNF-α-induced lung inflammation via the reduction of intercellular cell adhesion molecule-1 expression.Prostaglandin reductase 2 modulates ROS-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients.Symptom patterns of advanced cancer patients in a palliative care unit.Fear of death and good death among the young and elderly with terminal cancers in Taiwan.Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes.Magnolol reduced TNF-α-induced vascular cell adhesion molecule-1 expression in endothelial cells via JNK/p38 and NF-κB signaling pathways.PBMC expressed adiponectin mRNA is predictive of survival in patients with gastric cancer.Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.Correlates of fatigue phenomenon in palliative care patients with advance cancers in Taiwan.Changes of serum adiponectin and soluble intercellular adhesion molecule-1 concentrations after smoking cessation.Can a good death and quality of life be achieved for patients with terminal cancer in a palliative care unit?Pigment epithelium-derived factor reduces the PDGF-induced migration and proliferation of human aortic smooth muscle cells through PPARγ activation.Smokers show reduced circulating adiponectin levels and adiponectin mRNA expression in peripheral blood mononuclear cellsGanoderma lucidum polysaccharides prevent platelet-derived growth factor-stimulated smooth muscle cell proliferation in vitro and neointimal hyperplasia in the endothelial-denuded artery in vivoSignificance of symptom clustering in palliative care of advanced cancer patients
P50
Q34589939-30D16C5F-20FA-4D06-BA61-0760B1B0F6DAQ38874804-81EFC408-5DCB-49E8-9615-0F73F4DF6A06Q39274308-E2682D2C-C76A-4FF7-92A3-BF6CBFD9AE1BQ39344359-B2D4D307-F09A-4037-BB37-D630C61EA826Q39367714-8B659636-F406-4970-A5B2-81B8414410ABQ39699557-C7C05B77-0379-4D3B-B47B-EC324E6A611EQ43679637-A8BC1359-EEF8-4791-909A-E6AE0CEDFBDCQ45125979-ED345CF0-6C30-4041-ABD6-3DFAC00F8E5DQ45909026-D5A704CA-B92C-4008-954D-473C166027F1Q45955071-44EF6A20-5CC4-4765-A129-09B09993586FQ47612061-C02EDBCC-3444-47E0-8CC3-B4ACA4C71A93Q48738530-248B801A-A771-48AA-991E-8163363EDF82Q53206798-75B619C7-97FF-49FE-A2DB-E9F5EF844B00Q59656704-2C0070A6-10A3-44F7-8193-EB1A5274C26CQ82158227-3117B743-A8A1-4A8E-824A-34B3CE3C8EABQ83184883-644F8FAA-C00C-4B9C-A7E6-4719206C95E3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jaw-Shiun Tsai
@ast
Jaw-Shiun Tsai
@en
Jaw-Shiun Tsai
@es
Jaw-Shiun Tsai
@nl
Jaw-Shiun Tsai
@sl
type
label
Jaw-Shiun Tsai
@ast
Jaw-Shiun Tsai
@en
Jaw-Shiun Tsai
@es
Jaw-Shiun Tsai
@nl
Jaw-Shiun Tsai
@sl
prefLabel
Jaw-Shiun Tsai
@ast
Jaw-Shiun Tsai
@en
Jaw-Shiun Tsai
@es
Jaw-Shiun Tsai
@nl
Jaw-Shiun Tsai
@sl
P106
P1153
8364240200
P31
P496
0000-0002-5227-8894